Japanese pharmaceutical company Kyowa Hakko Kirin has announced the launch of its NESP injection 5μg plastic syringe as an additional formulation. Kyowa Hakko Kirin has obtained initial approval for NESP in July 2007. The long-acting ...
Tags: NESP, Kyowa Hakko Kirin, 5μg plastic, formulation
BioWa, a wholly owned subsidiary of Kyowa Hakko Kirin, and Lonza, a biotechnology company, have entered into a licensing agreement with MedImmune, the global biologics research and development arm of AstraZeneca. MedImmune has licensed ...
France-based NovAliX has entered into a fragment-based drug discovery project with Japanese biopharmaceutical firm Kyowa Hakko Kirin. The deal, which is a continuation of the alliance announced in January 2013, builds upon the positive ...
Kyowa Hakko Kirin, a pharmaceutical company, has received the Japanese approval for manufacturing and marketing the NESP injection 5μg plastic syringe as an additional formulation in Japan. NESP is a long-acting erythropoiesis ...
Tags: Plastic Syringe, Kyowa Hakko Kirin
Adimab signed a multi-target discovery agreement with Celgene Corporation, pursuant to which, Adimab will use its proprietary discovery and optimization platform to generate fully human antibodies against multiple targets. Under the terms ...
Tags: Adimab, Drug Discovery
Adimab and Innovent have collaborated to discover, develop and commercialise an antibody-based therapeutic, using Adimab antibody discovery and optimization platform, against a selected specific target. All initial product development ...
Tags: Adimab, Antibody-Based Therapeutic
Kyowa Hakko Kirin, Orexo's partner, has filed a new drug application (NDA) seeking Japanese approval for KW-2246 as cancer pain medication. The sublingual formulation of fentanyl earlier gained approval in US, EU and Canada as cancer ...
Tags: new drug application, cancer pain medication, pharmaceutical product
Orexo and ProStrakan Group have reconfigured the commercial rights to the product, Abstral, in various territories worldwide. Abstral is the novel, rapidly-disintegrating, sublingual (under the tongue) formulation of fentanyl, and an ...